Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 63.40
-0.10 (-0.16%)
Aug 19, 2026, 9:58 AM CST
Shine-On BioMedical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 61.81 | 49.17 | 44.66 | 102.02 | 373.16 | 824.98 |
Short-Term Investments | - | 873 | 999 | 1,035 | 793 | 81 |
Cash & Short-Term Investments | 808.81 | 922.17 | 1,044 | 1,137 | 1,166 | 905.98 |
Cash Growth | -15.45% | -11.64% | -8.21% | -2.50% | 28.72% | - |
Accounts Receivable | - | - | - | 10 | - | - |
Other Receivables | 2.09 | 2.74 | 2.31 | 2.06 | 1.18 | - |
Receivables | 2.09 | 2.74 | 2.31 | 12.06 | 1.18 | - |
Prepaid Expenses | 24.41 | 10.15 | 6.34 | 4.57 | 1.49 | 0.32 |
Other Current Assets | 0.05 | - | - | - | 0 | - |
Total Current Assets | 835.36 | 935.06 | 1,052 | 1,154 | 1,169 | 906.31 |
Property, Plant & Equipment | 0.75 | 1.4 | 2.83 | 1.54 | 3.03 | 3.99 |
Other Intangible Assets | 8.62 | 9.02 | 3.62 | 3.59 | 3.36 | 1.24 |
Long-Term Deferred Tax Assets | - | - | - | 0.04 | 2.27 | - |
Other Long-Term Assets | 5.46 | 5.46 | 1.03 | 0.89 | 0.28 | 0.28 |
Total Assets | 850.19 | 950.94 | 1,060 | 1,160 | 1,178 | 911.82 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | - | - | 2.86 | - | 0.19 |
Accrued Expenses | - | - | 0.26 | 0.57 | 0.01 | 1 |
Current Portion of Leases | - | 1.36 | 1.24 | 0.54 | 0.54 | 0.97 |
Other Current Liabilities | 53.23 | 42.18 | 39.09 | 19.29 | 2.61 | 0.59 |
Total Current Liabilities | 58.95 | 43.54 | 40.6 | 23.26 | 3.17 | 2.74 |
Long-Term Leases | - | - | 1.36 | - | 0.98 | 1.52 |
Long-Term Deferred Tax Liabilities | 0.04 | 0.12 | 0.26 | - | - | - |
Total Liabilities | 58.98 | 43.66 | 42.21 | 23.26 | 4.14 | 4.26 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 498 | 498 | 498 | 498 | 498 | 430 |
Additional Paid-In Capital | 703.6 | 703.6 | 703.6 | 703.6 | 703.6 | 486 |
Retained Earnings | -410.39 | -294.32 | -184.03 | -65.14 | -27.98 | -8.43 |
Shareholders' Equity | 791.21 | 907.28 | 1,018 | 1,136 | 1,174 | 907.57 |
Total Liabilities & Equity | 850.19 | 950.94 | 1,060 | 1,160 | 1,178 | 911.82 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 1.36 | 2.6 | 0.54 | 1.52 | 2.48 |
Net Cash (Debt) | 808.81 | 920.81 | 1,041 | 1,136 | 1,165 | 903.5 |
Net Cash Growth | -15.28% | -11.55% | -8.40% | -2.42% | 28.90% | - |
Net Cash Per Share | 16.17 | 18.45 | 20.90 | 22.82 | 25.65 | 48.91 |
Filing Date Shares Outstanding | 49.81 | 50.01 | 49.8 | 49.8 | 49.8 | 49.8 |
Total Common Shares Outstanding | 49.81 | 50.01 | 49.8 | 49.8 | 49.8 | 49.8 |
Working Capital | 776.42 | 891.53 | 1,012 | 1,130 | 1,166 | 903.57 |
Book Value Per Share | 15.88 | 18.14 | 20.43 | 22.82 | 23.57 | 18.22 |
Tangible Book Value | 782.59 | 898.26 | 1,014 | 1,133 | 1,170 | 906.33 |
Tangible Book Value Per Share | 15.71 | 17.96 | 20.36 | 22.75 | 23.50 | 18.20 |
Machinery | - | - | 1.23 | 1.86 | 1.79 | 1.31 |
Leasehold Improvements | - | - | 0.02 | 0.37 | 0.37 | 0.37 |